Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 4Head and Neck Neoplasms 4Breast Neoplasms 3Carcinoma, Squamous Cell 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Nodule 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neuroendocrine Cervical Cancer 1Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Motor Activity 1Meningioma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Lung Neoplasms 1Leukemia, Lymphoid 1Kidney Neoplasms 1Hypopharyngeal Neoplasms 1Hematologic Neoplasms 1Gynecologic Cancer 1Genetic Testing 1

Interventions

Cyclophosphamide 9fludarabine 5zanubrutinib 3Vincristine 3Rituximab 3Doxorubicin 3pirtobrutinib 2cemiplimab 2Specimen Handling 2Prednisone 2Magnetic Resonance Spectroscopy 2Leukapheresis 2Immunotherapy, Adoptive 2Etoposide 2Dexamethasone 2Cell- and Tissue-Based Therapy 2tafasitamab 1sodium-iodide symporter 1selinexor 1ruxolitinib 1pomalidomide 1polatuzumab vedotin 1obinutuzumab 1ibrutinib 1glofitamab 1etoposide phosphate 1blinatumomab 1acalabrutinib 1X-Rays 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, B-Cell × Surveys and Questionnaires × 30 days × Clear all
NCT07588698 2026-05-15

Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma

University of California, San Francisco

Phase 2 Not yet recruiting
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡